Evidence map›Paper›PMID 30085906›Full record

ArticleHuman vaccines & immunotherapeutics2018

Reiteration of the elimination status of measles in the southeast of Iran, 2015.

Shahrokh Izadi, Masoome Arabsalmani, Mahdi Mohammadi, Seyed Mehdi Tabatabaei, Ali-Akbar Haghdoost

Abstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shahrokh Izadia Health Promotion Research Centre, School of Public Health , Zahedan University of Medical Sciences , Zahedan , Iran.ORCID http://orcid.org/0000-0002-0496-7847
Masoome Arabsalmanib School of Public Health , Zahedan University of Medical Sciences , Zahedan , Iran.
Mahdi Mohammadic Health Promotion Research Centre, School of Public Health , Zahedan University of Medical Sciences , Zahedan , Iran.
Seyed Mehdi Tabatabaeia Health Promotion Research Centre, School of Public Health , Zahedan University of Medical Sciences , Zahedan , Iran.
Ali-Akbar Haghdoostd School of Public Health , Kerman University of Medical Sciences , Kerman , Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During 2015, the number of measles cases reported from Iran increased about three times the previous year; and Sistan-va-Baluchestan Province, located in the southeast of Iran, was the hottest point at the center of the dilemma. The main objective of the present study was to evaluate the situation of the population with regard to the elimination goals. The files of all measles cases were reviewed and categorized again based on surveillance system definitions; and the effective reproduction numbers, attack rates, and epidemic curves were calculated and graphed. In total, 152 laboratory-confirmed cases occurred in 2015 in the study population. The highest attack rate belonged to infants being in their first year of life and the lowest to the age groups 16 to 40. The estimated 'Effective Reproduction Number' for the eight districts ranged from 0.70 to 0.93; and considering the subsidence of all outbreaks by themselves, it might be speculated that elimination state is still in effect and accountable. Considering the large number of the susceptible islands among the sea of herd immune population, implicated by the large number of outbreaks, implementation of a supplementary immunization intervention is highly recommended.

Indexed as

EliminationImmunizationIranMeaslesOutbreak

Identifiers

PMID30085906
PMCPMC6343602

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.